Natriuretic peptides (NPs) are released from the heart in response to pressure and volume
overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important …

Hypertension and heart failure (HF) are common diseases that, despite advances in medical
therapy, continue to be associated with high morbidity and mortality. Therefore, innovative …

Context It is uncertain whether intensified heart failure therapy guided by N-terminal brain
natriuretic peptide (BNP) is superior to symptom-guided therapy. Objective To compare 18 …

Background—Heart failure (HF) is responsible for a huge burden in hospital care. Our goal
was to evaluate the value of N-terminal–pro-brain natriuretic peptide (NT-proBNP) in …

Biochemical marker testing has revolutionized the approach to diagnosis and management
of heart failure over the past decade. There is an unsurpassed excitement in the heart failure …

In patients with heart failure, plasma levels of atrial natriuretic peptide (ANP), B-type
natriuretic peptide (BNP), and the N-terminal fragments of their prohormones (N-ANP and N …

Many claims have been made in recent years regarding the utility of plasma B-type
natriuretic peptide (BNP) concentration measurements in the diagnosis, risk stratification …

The key concept of proteomics (looking at many proteins at once) opens new avenues in the
search for clinically useful biomarkers of disease, treatment response and ageing. As the …

Background B-Type natriuretic peptide (BNP), a protein released from the left ventricle in
response to volume expansion and pressure overload, has emerged as the first whole blood …

Background—The diagnostic and prognostic values of plasma B-type natriuretic peptide
(BNP) testing are established. However, the range of plasma BNP levels present in the …